PRELIMINARY CONSULTATION: Australian Evidence-Based Clinical Guidelines for Diabetes

Main Editor Living Evidence for Diabetes Consortium
Language en
Last Update Dec 18, 2019
Published Date Dec 18, 2019
Contact
Disclaimer

These clinical guidelines are a general guide to appropriate practice, to be followed subject to the clinician’s judgement and the patient’s preference in each individual case. The guidelines are not intended to be proscriptive. They are designed to provide information to assist decision making and have been informed by the highest quality evidence available at the time of compilation. Accordingly, the parties involved in the development of these guidelines shall have no liability to any users of the information contained in this publication for any loss or damage, cost or expense incurred or arising from reliance on the information contained in this publication.   
 

Sponsors Funding and in-kind support for the development of these clinical guidelines was provided by the Department of Health Chronic Disease Policy Section, Monash University Division of Metabolism, Ageing and Genomics, Australian Diabetes Society, Australian Diabetes Educators Association Cochrane, Diabetes Australia, Australian Paediatric Endocrine Group and Cochrane Australia.
 
 
Abstract

PICOS
PICO 1.1
P: Adults with type 1 diabetes
I: CGM with alerts + MDI
C: SMBG + MDI
O:

PICO 2.1
P: PICO 6a - CSII vs MDI in children with type 1 diabetes
I: CSII
C: MDI
O:

PICO 3.1
P: Tech PICO 3 CSII+CGM vs AutoCSII
I: AutoCSII
C: Control
O:

PICO 1.2
P: Adults with Type 1 diabetes
I: CGM without alerts + MDI
C: SMBG+MDI
O:

PICO 2.2
P: Adults with Type 1 Diabetes
I: Insulin Pump (CSII)
C: Multiple Daily Injections (MDI)
O:

PICO 1.3
P: Adults with type 1 diabetes
I: Flash + MDI
C: SMBG + MDI
O: